Medical School · Year 4 · Critical Care · includes a quiz and discussion video
Seminar 2: Mechanical Ventilation
Year 4: Critical Care Elective
Learning Objectives
By the end of this seminar, students will be able to:
- Identify clinical indications for mechanical ventilation and evaluate patients for non-invasive ventilation alternatives
- Differentiate ventilator modes including volume control, pressure control, and pressure support with appropriate clinical applications
- Calculate ideal body weight and prescribe initial ventilator settings using lung-protective strategies
- Recognize and manage acute respiratory distress syndrome according to evidence-based protocols including prone positioning
- Troubleshoot common ventilator alarms and manage patient-ventilator dyssynchrony
- Assess weaning readiness, conduct spontaneous breathing trials, and safely extubate patients
I. Indications for Mechanical Ventilation
Respiratory failure represents the primary indication for mechanical ventilation and is classified according to the predominant gas exchange abnormality. Type I hypoxemic respiratory failure is characterized by arterial oxygen tension (PaO2) below 60 mmHg with normal or low carbon dioxide levels, occurring in conditions such as pneumonia, pulmonary edema, and acute respiratory distress syndrome. Type II hypercapnic respiratory failure manifests with elevated PaCO2 above 50 mmHg and decreased pH, seen in COPD exacerbations, neuromuscular weakness, and drug overdoses causing respiratory depression. Type III respiratory failure occurs in the peri-operative period due to atelectasis, residual anesthetic effects, and surgical complications. Type IV respiratory failure develops in shock states where mechanical ventilation reduces oxygen consumption by respiratory muscles and ensures adequate oxygenation during resuscitation.
Clinical indications beyond blood gas derangements guide intubation decisions based on the overall clinical picture. Acute respiratory failure from pneumonia, ARDS, or other parenchymal lung diseases may require ventilatory support when non-invasive measures fail. Airway protection becomes necessary when decreased level of consciousness, as indicated by Glasgow Coma Scale scores below 8, impairs the ability to maintain airway patency and protect against aspiration. Increased work of breathing with respiratory muscle fatigue, evidenced by accessory muscle use, paradoxical abdominal breathing, and patient distress, indicates impending respiratory collapse. Shock states may warrant intubation to reduce the metabolic demand of labored breathing and secure the airway for anticipated procedures.
Non-invasive ventilation (NIV) represents an important alternative to intubation in selected patients who can protect their airway. Continuous positive airway pressure (CPAP) provides a single level of positive pressure throughout the respiratory cycle and is particularly effective for acute cardiogenic pulmonary edema. Bilevel positive airway pressure (BiPAP) delivers higher pressure during inspiration than expiration, augmenting tidal volumes in patients with hypercapnic respiratory failure from COPD exacerbations. High-flow nasal cannula (HFNC) provides heated, humidified oxygen at flow rates up to 60 liters per minute, generating modest positive pressure and improving oxygenation in hypoxemic respiratory failure. Contraindications to NIV include inability to protect the airway, hemodynamic instability, copious secretions, and facial trauma preventing mask seal.
The decision to proceed with endotracheal intubation requires assessment of the clinical trajectory and response to less invasive interventions. A worsening trajectory despite appropriate therapy signals the need for escalation before cardiopulmonary arrest occurs. Failure to improve with non-invasive ventilation after an adequate trial indicates the need for intubation. Impending or actual airway compromise from altered mental status, airway edema, or massive secretions cannot be adequately managed non-invasively. Hemodynamic instability requiring aggressive resuscitation warrants airway control to facilitate safe sedation and prevent aspiration. The goal is early identification of patients who will benefit from intubation before emergent, uncontrolled circumstances develop.
<image>Figure 1. Indications for Mechanical Ventilation. Panel A classifies respiratory failure types including Type I hypoxemic, Type II hypercapnic, Type III peri-operative, and Type IV shock-related with their characteristic features. Panel B lists clinical indications including acute respiratory failure, airway protection, increased work of breathing, and shock. Panel C compares non-invasive ventilation options including CPAP, BiPAP, and HFNC with appropriate clinical applications. Panel D outlines decision criteria for intubation based on trajectory, response to therapy, airway status, and hemodynamic stability.</image>
II. Ventilator Modes
Volume-controlled ventilation (VC) delivers a preset tidal volume with each breath regardless of the pressure required to achieve that volume. The clinician sets the tidal volume, respiratory rate, and inspiratory flow rate, while the resulting airway pressure varies based on lung compliance and resistance. This mode guarantees minute ventilation, making it the most commonly used initial mode in critically ill patients. Peak inspiratory pressure reflects both resistive and elastic components of the respiratory system, while plateau pressure measured during an inspiratory hold reflects only elastic recoil and correlates with alveolar distending pressure. The primary disadvantage is that with poor compliance, high pressures may develop, risking barotrauma.
Pressure-controlled ventilation (PC) delivers breaths at a preset inspiratory pressure with variable tidal volumes depending on respiratory system mechanics. The clinician sets the inspiratory pressure, respiratory rate, and inspiratory-to-expiratory (I:E) ratio, while tidal volume varies with changes in compliance and resistance. This mode limits peak airway pressures, potentially reducing barotrauma risk in patients with heterogeneous lung disease such as ARDS. The decelerating flow pattern may improve gas distribution in some circumstances. However, tidal volumes are not guaranteed and may decrease with worsening compliance, requiring close monitoring to ensure adequate ventilation.
Pressure support ventilation (PS) provides patient-triggered, pressure-assisted breaths for spontaneously breathing patients. The clinician sets the level of pressure support, while the patient controls respiratory rate, tidal volume, and inspiratory time based on their own respiratory drive. Each breath is triggered by patient effort, augmented by the set pressure, and terminated when inspiratory flow decreases to a percentage of peak flow. This mode requires intact respiratory drive and is commonly used during weaning to gradually reduce ventilatory support. The work of breathing decreases with higher pressure support levels, allowing titration based on patient comfort and respiratory effort.
Synchronized intermittent mandatory ventilation (SIMV) combines mandatory breaths at a set rate with the opportunity for additional spontaneous breaths between mandatory cycles. Mandatory breaths are synchronized to patient effort when present, reducing dyssynchrony compared to older assist-control modes. Spontaneous breaths between mandatory cycles can be supported with pressure support to reduce patient work of breathing. This mode was historically popular for weaning by gradually reducing the mandatory rate, though evidence suggests pressure support weaning may be faster. SIMV may be useful in specific situations where guaranteed minimum minute ventilation is desired while allowing patient interaction with the ventilator.
<image>Figure 2. Ventilator Modes. Panel A illustrates volume-controlled ventilation showing fixed tidal volume delivery with variable pressure and typical flow and pressure waveforms. Panel B demonstrates pressure-controlled ventilation with fixed pressure delivery, variable tidal volumes, and characteristic decelerating flow pattern. Panel C shows pressure support ventilation as a patient-triggered mode with clinician-set pressure augmentation of spontaneous breaths. Panel D depicts SIMV combining mandatory and spontaneous breaths with optional pressure support.</image>
III. Initial Ventilator Settings
Tidal volume selection fundamentally influences outcomes in mechanically ventilated patients. The landmark ARDS Network trial established that low tidal volume ventilation at 6 mL/kg of ideal body weight reduces mortality compared to traditional volumes of 12 mL/kg. This lung-protective strategy applies to all patients with ARDS, and evidence supports its use in patients without ARDS as well, with volumes of 6-8 mL/kg being appropriate for most critically ill patients. Tidal volume must always be calculated using ideal body weight based on height, not actual body weight, as lung size correlates with height rather than total body mass. Using actual body weight in obese patients leads to excessive tidal volumes that increase ventilator-induced lung injury risk.
Ideal body weight calculation follows established formulas based on height and sex. For males, ideal body weight in kilograms equals 50 plus 2.3 times the number of inches over 60 (or 50 plus 0.91 times height in centimeters minus 152.4). For females, ideal body weight equals 45.5 plus 2.3 times inches over 60 (or 45.5 plus 0.91 times centimeters minus 152.4). Accurate height measurement is essential since small errors significantly impact calculated tidal volumes. When direct measurement is not possible, height can be estimated from arm span or recalled from prior documentation.
Initial settings beyond tidal volume require systematic consideration of oxygenation, ventilation, and respiratory mechanics. Initial FiO2 is typically set at 100% and rapidly weaned based on oxygen saturation to minimize oxygen toxicity, targeting SpO2 of 92-96% in most patients. Initial positive end-expiratory pressure (PEEP) of 5-8 cmH2O prevents alveolar derecruitment; higher levels may be needed in ARDS. Respiratory rate is typically set at 12-16 breaths per minute and adjusted based on pH and PaCO2 targets. The I:E ratio is usually set at 1:2 to 1:3, allowing adequate expiratory time. In volume-controlled modes, inspiratory flow rate is typically set at 60 L/min.
Goals of mechanical ventilation target adequate oxygenation and ventilation while avoiding lung injury. Oxygen saturation targets of 92-96% provide adequate tissue oxygenation while avoiding hyperoxia, which may cause harm in certain conditions. Arterial pH is targeted between 7.30 and 7.45, accepting mild hypercapnia (permissive hypercapnia) when necessary to maintain lung-protective tidal volumes. Plateau pressure should remain below 30 cmH2O to minimize alveolar overdistension. Achieving these goals requires ongoing adjustment of ventilator settings based on blood gas results and respiratory mechanics measurements.
<image>Figure 3. Initial Ventilator Settings. Panel A presents tidal volume recommendations showing 6 mL/kg for ARDS and 6-8 mL/kg for non-ARDS patients calculated using ideal body weight. Panel B provides formulas for calculating ideal body weight based on height for males and females. Panel C outlines initial settings for FiO2, PEEP, respiratory rate, I:E ratio, and flow rate with typical starting values. Panel D summarizes ventilation goals including oxygen saturation, pH range, and plateau pressure limits.</image>
IV. Lung-Protective Ventilation
Core principles of lung-protective ventilation aim to minimize ventilator-induced lung injury while maintaining adequate gas exchange. Low tidal volume ventilation at 6 mL/kg ideal body weight reduces cyclic overdistension of aerated alveoli. Limiting plateau pressure to below 30 cmH2O prevents static overdistension at end-inspiration. Permissive hypercapnia accepts elevated PaCO2 levels to maintain protective ventilation when normal ventilation would require injurious volumes or pressures. Adequate PEEP maintains alveolar recruitment and prevents repetitive opening and closing of unstable lung units. These principles work together to reduce the inflammatory response triggered by mechanical ventilation.
The ARDS Network protocol provides a standardized approach to implementing lung-protective ventilation validated by landmark clinical trials. Tidal volume is set at 6 mL/kg ideal body weight, reduced to as low as 4 mL/kg if needed to keep plateau pressure below 30 cmH2O. Plateau pressure is measured during an inspiratory pause and targeted below 30 cmH2O, with adjustments to tidal volume if exceeded. Respiratory rate is increased up to 35 breaths per minute to compensate for reduced tidal volume and maintain pH above 7.20. PEEP and FiO2 are adjusted according to standardized tables based on oxygenation requirements. This protocol reduced mortality by 22% in the original trial.
Driving pressure represents an important metric associated with outcomes in ARDS patients. Driving pressure is calculated as plateau pressure minus PEEP and reflects the pressure required to inflate the aerated lung. A driving pressure below 15 cmH2O is associated with improved survival. This metric normalizes tidal volume for available lung capacity, as patients with severe ARDS have reduced aerated lung volume (baby lung concept). Driving pressure may be more strongly associated with mortality than tidal volume or plateau pressure alone. Strategies that reduce driving pressure, including adjusting PEEP to optimize compliance, may improve outcomes.
Ventilator-induced lung injury occurs through several mechanisms that lung-protective strategies address. Volutrauma results from overdistension of alveoli, prevented by low tidal volume ventilation. Barotrauma from excessive airway pressures causes air leaks and pneumothorax, prevented by limiting plateau pressure. Atelectrauma occurs from repetitive opening and closing of unstable alveoli, prevented by adequate PEEP to maintain recruitment. Biotrauma refers to the inflammatory cascade triggered by mechanical stress, reduced through all lung-protective measures. Understanding these mechanisms reinforces the importance of each component of the protective ventilation strategy.
<image>Figure 4. Lung-Protective Ventilation. Panel A outlines core principles including low tidal volume, plateau pressure limits, permissive hypercapnia, and adequate PEEP. Panel B summarizes the ARDS Network protocol with specific targets for tidal volume, plateau pressure, respiratory rate, and PEEP/FiO2 adjustments. Panel C explains driving pressure calculation and its significance as an outcome predictor. Panel D illustrates mechanisms of ventilator-induced lung injury including volutrauma, barotrauma, atelectrauma, and biotrauma with corresponding prevention strategies.</image>
V. ARDS Management
The Berlin definition provides standardized criteria for diagnosing and classifying acute respiratory distress syndrome severity. ARDS requires bilateral opacities on chest imaging not fully explained by effusions, collapse, or nodules. The timing criterion specifies onset within one week of a known clinical insult or new or worsening respiratory symptoms. The origin of edema must not be fully explained by cardiac failure or fluid overload, though cardiac dysfunction may coexist. Severity classification uses the ratio of arterial oxygen tension to inspired oxygen fraction (P/F ratio): mild ARDS has P/F 200-300 mmHg, moderate ARDS has P/F 100-200 mmHg, and severe ARDS has P/F below 100 mmHg. These severity categories correlate with mortality and guide treatment intensity.
Initial management of ARDS focuses on lung-protective ventilation, fluid management, and treatment of the underlying cause. Mechanical ventilation using the ARDS Network protocol with tidal volumes of 6 mL/kg and plateau pressures below 30 cmH2O forms the cornerstone of supportive care. PEEP titration maintains oxygenation while preventing derecruitment, with higher PEEP levels often needed in moderate and severe ARDS. Conservative fluid management after initial resuscitation improves oxygenation and reduces ventilator days without increasing organ failures. Identification and treatment of the underlying cause, whether pneumonia, sepsis, aspiration, or other insult, addresses the inciting pathology.
Advanced interventions are reserved for patients with refractory hypoxemia despite initial lung-protective measures. Prone positioning for 12-16 hours daily improves oxygenation and reduces mortality in patients with P/F ratio below 150 mmHg. Neuromuscular blockade may benefit patients with severe ARDS (P/F below 150) who have ventilator dyssynchrony, though recent trials show less benefit than initially demonstrated. Inhaled pulmonary vasodilators including nitric oxide and epoprostenol improve oxygenation without mortality benefit and serve as rescue therapy. Veno-venous extracorporeal membrane oxygenation (ECMO) provides gas exchange support for the most severe, refractory cases with potentially reversible underlying disease.
Prone positioning deserves special attention as a mortality-reducing intervention in severe ARDS. The PROSEVA trial demonstrated a 16% absolute mortality reduction with prone positioning for at least 16 hours daily in patients with P/F below 150. Improved oxygenation results from more homogeneous ventilation, better V/Q matching, and improved secretion drainage. Contraindications include spinal instability, open abdominal wounds, hemodynamic instability, and pregnancy. Complications include pressure injuries on the face and dependent areas, endotracheal tube displacement or obstruction, and vascular catheter complications. Careful positioning protocols and trained teams minimize these risks while achieving the survival benefit.
<image>Figure 5. ARDS Management. Panel A presents the Berlin definition criteria including timing, imaging, origin of edema, and P/F ratio-based severity classification. Panel B outlines initial management strategies including lung-protective ventilation, PEEP titration, conservative fluids, and treatment of underlying cause. Panel C describes advanced interventions including prone positioning, neuromuscular blockade, inhaled vasodilators, and ECMO with their indications. Panel D details prone positioning implementation including duration, contraindications, complications, and mortality benefit.</image>
VI. Troubleshooting Ventilator Alarms
High pressure alarms indicate increased resistance to airflow or decreased compliance requiring prompt evaluation and intervention. Secretions obstructing the endotracheal tube or airways represent the most common cause, addressed by suctioning. Bronchospasm increases airway resistance and responds to bronchodilator administration. Patient-ventilator dyssynchrony with the patient fighting the ventilator triggers pressure alarms and may require sedation adjustment or ventilator setting changes. Tension pneumothorax causes sudden high pressures with hemodynamic compromise, requiring immediate needle decompression followed by chest tube placement. Mainstem bronchus intubation from endotracheal tube migration increases pressures due to single-lung ventilation and is corrected by withdrawing the tube to the proper position.
Low pressure alarms signal loss of circuit integrity or inadequate pressure generation. Circuit disconnection is the most common cause, immediately evident on inspection and corrected by reconnection. Endotracheal tube cuff leak allows air escape around the cuff, detected by audible leak and low exhaled volumes, requiring cuff inflation or tube exchange. Dislodgement of the endotracheal tube to a supraglottic position causes complete loss of ventilation and requires immediate airway reassessment and reintubation. Air leaks at circuit connections or through humidifier systems require systematic inspection and tightening or replacement of faulty components.
Hypoxemia occurring on the ventilator requires systematic evaluation of equipment, airway, and patient factors. Endotracheal tube malposition including mainstem intubation or dislodgement is evaluated by chest radiograph and clinical examination. Pneumothorax should be suspected with sudden deterioration and evaluated clinically and radiographically, with immediate decompression if tension pneumothorax is present. Mucus plugging causes segmental or lobar atelectasis and may require suctioning or bronchoscopy for clearance. Worsening underlying disease progression, whether ARDS, pneumonia, or pulmonary edema, may require increased FiO2, PEEP, or other therapeutic adjustments. Pulmonary embolism should be considered in patients with risk factors and unexplained hypoxemia.
Patient distress on the ventilator reflects inadequate comfort that requires comprehensive assessment beyond simply increasing sedation. Pain should be assessed and treated first, as uncontrolled pain manifests as agitation and ventilator dyssynchrony. Anxiety responds to reassurance, reorientation, and anxiolytic medications when non-pharmacological measures are insufficient. Dyssynchrony between patient effort and ventilator delivery requires ventilator adjustment, potentially including mode change, flow rate modification, or trigger sensitivity adjustment. Hypoxia and hypercapnia cause air hunger and distress, requiring blood gas analysis and ventilator adjustment. Increased support through higher pressure support or assisted modes may be needed when patient demand exceeds ventilator delivery.
<image>Figure 6. Troubleshooting Ventilator Alarms. Panel A lists causes of high pressure alarms including secretions, bronchospasm, dyssynchrony, pneumothorax, and mainstem intubation with corresponding interventions. Panel B describes causes of low pressure alarms including circuit disconnection, cuff leak, tube dislodgement, and circuit air leaks. Panel C outlines systematic evaluation of hypoxemia on the ventilator addressing tube position, pneumothorax, mucus plugging, disease progression, and pulmonary embolism. Panel D presents the approach to patient distress considering pain, anxiety, dyssynchrony, and inadequate support.</image>
VII. Sedation and Analgesia for Mechanical Ventilation
Analgesia-first sedation recognizes that pain represents a primary source of discomfort in mechanically ventilated patients. The endotracheal tube itself causes significant discomfort, and patients frequently experience procedural pain, positioning discomfort, and pain from underlying illness or injury. Addressing pain before adding sedatives often reduces total sedation requirements and improves patient outcomes. Pain assessment in non-communicative patients uses validated behavioral tools. The Behavioral Pain Scale (BPS) evaluates facial expression, upper limb movements, and ventilator compliance. The Critical Care Pain Observation Tool (CPOT) assesses facial expression, body movements, muscle tension, and ventilator compliance or vocalization.
Opioid selection considers pharmacokinetic properties, organ function, and clinical context. Fentanyl offers rapid onset, short duration of action, and metabolism to inactive compounds, making it a preferred agent in critically ill patients. Hydromorphone provides an alternative for patients requiring prolonged analgesia, with attention to accumulation in renal impairment. Morphine should be avoided or used cautiously in renal failure due to accumulation of the active metabolite morphine-6-glucuronide. Remifentanil offers ultra-short action ideal for procedural sedation or rapid neurological assessment but requires continuous infusion. Continuous opioid infusions with bolus dosing for breakthrough pain optimize comfort while facilitating regular assessment.
Sedation strategies have evolved toward lighter targets supported by evidence of improved outcomes. Propofol provides rapid onset and offset with easy titration, though hypotension may limit use in hemodynamically unstable patients and prolonged high-dose infusions carry risks including propofol infusion syndrome. Dexmedetomidine produces light sedation with preserved respiratory drive and may reduce delirium, though hypotension and bradycardia occur. Midazolam was historically a mainstay but accumulates with prolonged use, prolongs duration of mechanical ventilation, and increases delirium risk. Ketamine provides sedation with bronchodilator properties and preserved hemodynamics, increasingly used as an adjunct in selected patients.
Sedation goals target light sedation sufficient for patient comfort and safety while maintaining the ability to participate in assessment and rehabilitation. The Richmond Agitation-Sedation Scale (RASS) provides a validated 10-point scale from +4 (combative) through 0 (alert and calm) to -5 (unarousable). Typical targets of RASS -2 to 0 allow patient interaction while preventing agitation. Deep sedation is reserved for specific indications such as refractory intracranial hypertension, prone positioning, or neuromuscular blockade. Daily spontaneous awakening trials interrupt sedation to assess neurological status and readiness for weaning, improving outcomes when coordinated with spontaneous breathing trials.
<image>Figure 7. Sedation and Analgesia. Panel A establishes the principle of analgesia-first sedation with pain assessment tools including BPS and CPOT for non-communicative patients. Panel B compares opioid agents including fentanyl, hydromorphone, morphine, and remifentanil with their properties and considerations. Panel C describes sedative agents including propofol, dexmedetomidine, midazolam, and ketamine with advantages and disadvantages. Panel D presents sedation goals using the RASS scale, typical targets, indications for deeper sedation, and the role of daily awakening trials.</image>
VIII. Weaning from Mechanical Ventilation
Readiness criteria identify patients likely to succeed with ventilator liberation attempts. Oxygenation requirements should be modest, with FiO2 at or below 40% and PEEP at or below 8 cmH2O indicating adequate gas exchange with minimal support. Hemodynamic stability with absent or low-dose vasopressor requirements ensures adequate cardiovascular reserve to meet increased metabolic demands of spontaneous breathing. Neurological status should include alertness and ability to follow commands, ensuring adequate respiratory drive and airway protection. Resolution of the condition precipitating mechanical ventilation indicates the underlying pathology has improved sufficiently. Absence of significant metabolic derangements including severe acidosis ensures physiological conditions support successful weaning.
Spontaneous breathing trial (SBT) protocols assess the ability to sustain independent respiration. T-piece trials completely remove ventilator support, with the patient breathing through the endotracheal tube connected only to supplemental oxygen. Low-level pressure support of 5-8 cmH2O approximates the resistance added by the endotracheal tube, providing more physiological conditions. CPAP trials at 5 cmH2O maintain circuit pressure without inspiratory support. Trial duration typically ranges from 30 to 120 minutes, with shorter trials (30 minutes) as effective as longer ones for predicting extubation success. Continuous monitoring during the trial identifies patients developing distress who require return to full support.
Failure criteria identify patients unable to tolerate spontaneous breathing who should not proceed to extubation. Respiratory rate exceeding 35 breaths per minute indicates excessive work of breathing. Oxygen saturation falling below 90% despite supplemental oxygen signals inadequate gas exchange. Heart rate increasing more than 20% from baseline or development of arrhythmias suggests cardiovascular stress. Signs of respiratory distress including accessory muscle use, paradoxical breathing, diaphoresis, and patient distress indicate failure. The rapid shallow breathing index (RSBI), calculated as respiratory rate divided by tidal volume in liters, above 105 predicts extubation failure. Patients failing the SBT return to full support with investigation of underlying causes.
Extubation proceeds for patients successfully completing the spontaneous breathing trial. Pre-extubation preparation includes thorough suctioning of secretions and preoxygenation with 100% FiO2. Cuff leak testing by deflating the cuff and assessing for air leak around the tube may identify patients at risk for post-extubation stridor from laryngeal edema; absent leak may prompt systemic corticosteroids before extubation. Post-extubation monitoring in the ICU allows rapid detection and management of respiratory deterioration. Prophylactic non-invasive ventilation immediately following extubation reduces reintubation rates in high-risk patients including those with hypercapnia, cardiac disease, or failed prior extubation attempts.
<image>Figure 8. Weaning from Mechanical Ventilation. Panel A lists readiness criteria including oxygenation requirements, hemodynamic stability, neurological status, disease resolution, and metabolic stability. Panel B describes spontaneous breathing trial methods including T-piece, low pressure support, and CPAP with typical duration and monitoring requirements. Panel C presents SBT failure criteria including respiratory rate, oxygen saturation, heart rate, distress signs, and RSBI threshold. Panel D outlines the extubation process including preparation, cuff leak assessment, monitoring, and prophylactic non-invasive ventilation for high-risk patients.</image>
IX. Liberation Protocols
Daily assessment protocols systematically identify patients ready for weaning and track progress toward liberation. Each morning, readiness criteria are reviewed to determine eligibility for spontaneous breathing trial. Patients passing the SBT proceed to extubation when appropriate. Patients failing the SBT return to full support with identification of the cause of failure. The cause is addressed through targeted intervention, and reassessment occurs within 24 hours. This systematic approach prevents prolonged mechanical ventilation from failure to recognize weaning readiness while ensuring patients are not extubated prematurely.
Addressing failure causes requires diagnosis-specific interventions to improve the likelihood of subsequent SBT success. Cardiac causes of weaning failure, including fluid overload and myocardial ischemia, respond to diuresis and cardiac optimization. Secretion management through chest physiotherapy, mucolytics, and bronchoscopy when needed addresses pulmonary toilet issues. Delirium impairs cooperation with weaning and requires investigation and treatment of underlying causes along with non-pharmacological interventions. ICU-acquired weakness from critical illness polyneuropathy and myopathy responds to aggressive physical therapy and mobilization. Anxiety and psychological factors may require reassurance, anxiolysis, and graduated weaning approaches.
Prolonged mechanical ventilation, defined as ventilator dependence exceeding 21 days, requires consideration of tracheostomy and specialized care settings. Tracheostomy provides secure airway access, improves patient comfort, facilitates oral care and nutrition, and enables speech with appropriate valves. Timing of tracheostomy remains debated, though most centers consider the procedure between days 7 and 14 in patients expected to require prolonged ventilation. Long-term acute care facilities and specialized weaning units provide focused rehabilitation and weaning attempts for patients requiring extended ventilator support. Goals of care discussions address prognosis and patient preferences for those with prolonged ventilator dependence.
Outcome metrics track ventilator liberation performance and guide quality improvement. Ventilator days represent a key metric, with protocols targeting minimization of time on mechanical support. Ventilator-associated pneumonia rates reflect preventive bundle compliance and have direct mortality implications. Reintubation rates within 48-72 hours of extubation indicate whether weaning assessment is appropriately identifying ready patients. ICU length of stay correlates with ventilator duration and reflects overall efficiency of care. Tracking these metrics enables identification of opportunities for improvement and benchmarking against other institutions.
<image>Figure 9. Liberation Protocols. Panel A outlines daily assessment workflow including readiness screening, SBT, extubation decision, and reassessment after failure. Panel B describes diagnosis-specific interventions for weaning failure including cardiac optimization, secretion management, delirium treatment, and weakness rehabilitation. Panel C addresses prolonged mechanical ventilation considerations including tracheostomy timing and specialized care settings. Panel D presents outcome metrics for tracking liberation performance including ventilator days, VAP rates, reintubation rates, and ICU length of stay.</image>
X. Special Ventilator Situations
Obstructive lung disease, including COPD and asthma, requires ventilator settings that account for increased airway resistance and risk of air trapping. Respiratory rate should be set lower than usual (8-12 breaths per minute) to allow adequate time for expiration. The I:E ratio is extended to 1:3 or 1:4, maximizing expiratory time. Lower PEEP settings may be appropriate, though some extrinsic PEEP matching intrinsic auto-PEEP can reduce triggering work. Auto-PEEP (intrinsic PEEP) should be monitored regularly through expiratory hold maneuvers, as elevated levels indicate inadequate expiratory time and risk hemodynamic compromise. Bronchodilators administered through the ventilator circuit address reversible airway obstruction.
Neurological injury from traumatic brain injury, stroke, or other intracranial pathology requires ventilation strategies that avoid secondary brain injury. Hypoxia must be strictly avoided as it worsens neurological outcomes; oxygen saturation targets are typically 94-98% or higher. Normocapnia with PaCO2 targets of 35-40 mmHg maintains appropriate cerebral blood flow; hyperventilation causes vasoconstriction and may worsen ischemia. Head of bed elevation to 30 degrees promotes venous drainage and reduces intracranial pressure. When intracranial pressure monitoring is available, ventilator adjustments may be guided by cerebral perfusion pressure targets. Brief hyperventilation may be used as a temporizing measure for acute herniation but not as sustained therapy.
Post-cardiac arrest management integrates ventilation with targeted temperature management protocols. Targeted temperature management at 32-36 degrees Celsius according to institutional protocols is standard of care for comatose survivors. Hyperventilation should be avoided as it may worsen cerebral ischemia through vasoconstriction; targets maintain normal PaCO2. Hyperoxia (PaO2 greater than 300 mmHg) may worsen neurological outcomes, prompting FiO2 weaning once adequate oxygenation is achieved. Neuroprognostication should be delayed at least 72 hours from return of spontaneous circulation and longer if sedation or paralysis may confound the examination. Ventilator management supports overall resuscitation while minimizing secondary brain injury.
Morbid obesity presents unique ventilator management challenges due to altered respiratory mechanics. Ideal body weight calculated from height, not actual weight, must be used for tidal volume calculation to avoid injurious overdistension. Higher PEEP levels are often needed to counteract the mass effect of abdominal and chest wall adiposity on functional residual capacity. Reverse Trendelenburg positioning with head of bed elevated reduces diaphragmatic compression and improves respiratory mechanics. Recruitment maneuvers may be needed to open atelectatic lung units. Careful attention to these factors enables lung-protective ventilation in obese patients while achieving adequate gas exchange.
<image>Figure 10. Special Ventilator Situations. Panel A describes ventilator management for obstructive lung disease including rate reduction, extended I:E ratio, PEEP considerations, auto-PEEP monitoring, and bronchodilator use. Panel B outlines neurological injury considerations including avoidance of hypoxia, normocapnia targets, head positioning, and intracranial pressure management. Panel C presents post-cardiac arrest ventilation strategy including temperature management, avoidance of hyperventilation and hyperoxia, and timing of neuroprognostication. Panel D addresses morbid obesity challenges including proper tidal volume calculation, higher PEEP requirements, positioning strategies, and recruitment maneuvers.</image>
Summary
Mechanical ventilation is indicated for respiratory failure, airway protection, increased work of breathing, and shock states, with non-invasive ventilation considered first when appropriate. Ventilator modes include volume-controlled (most common, guaranteed tidal volume), pressure-controlled (limited pressure, variable volume), and pressure support (patient-triggered, for weaning). Initial settings use tidal volumes of 6-8 mL/kg ideal body weight calculated from height, initial FiO2 of 100% rapidly weaned, PEEP of 5-8 cmH2O, and rate of 12-16 breaths per minute. Lung-protective ventilation limits tidal volume to 6 mL/kg, plateau pressure to below 30 cmH2O, and driving pressure to below 15 cmH2O while accepting permissive hypercapnia. ARDS management follows the Berlin definition severity classification and includes lung-protective ventilation, prone positioning for P/F below 150, conservative fluid management, and consideration of neuromuscular blockade or ECMO for refractory cases. Troubleshooting addresses high pressure alarms (obstruction, bronchospasm, dyssynchrony, pneumothorax), low pressure alarms (disconnection, cuff leak), and hypoxemia through systematic evaluation. Sedation follows analgesia-first principles with light sedation targets (RASS -2 to 0) and daily awakening trials. Weaning assessment uses spontaneous breathing trials when FiO2 is 40% or less and PEEP is 8 cmH2O or less, with RSBI below 105 predicting success. Liberation protocols systematically assess readiness daily, address failure causes, and track outcomes. Special situations require modified approaches for obstructive disease (lower rate, longer expiration), neurological injury (normocapnia), and obesity (PEEP, positioning).
Key Terms
ARDS (Acute Respiratory Distress Syndrome): A syndrome of acute hypoxemic respiratory failure with bilateral pulmonary infiltrates not explained by cardiac failure, classified by P/F ratio into mild, moderate, and severe categories.
IBW (Ideal Body Weight): The weight used for tidal volume calculation based on height and sex, reflecting lung size rather than total body mass; males: 50 + 2.3(inches over 60); females: 45.5 + 2.3(inches over 60).
PEEP (Positive End-Expiratory Pressure): Pressure maintained in the airways at end-expiration to prevent alveolar collapse and maintain recruitment, typically set at 5-8 cmH2O initially with higher levels in ARDS.
SBT (Spontaneous Breathing Trial): A diagnostic test of the ability to breathe without ventilator support, conducted with T-piece or minimal pressure support for 30-120 minutes to assess extubation readiness.
RSBI (Rapid Shallow Breathing Index): A weaning predictor calculated as respiratory rate divided by tidal volume in liters; values below 105 predict successful extubation.
Driving Pressure: The difference between plateau pressure and PEEP, representing the pressure required to inflate the aerated lung; values below 15 cmH2O are associated with improved outcomes in ARDS.
Volutrauma: Lung injury caused by overdistension of alveoli from excessive tidal volumes, prevented by lung-protective low tidal volume ventilation.
VAP (Ventilator-Associated Pneumonia): Hospital-acquired pneumonia developing more than 48 hours after intubation, with prevention bundles including head of bed elevation, oral care, and weaning protocols.
This content is subject to the MIT License. © 2024–2026 Hibbert School of Medicine.
